Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kath Kerry

- PMLiVE

Novartis reports positive phase 3 results for Cosentyx in polymyalgia rheumatica

The REPLENISH trial met all primary and secondary endpoints, demonstrating sustained remission vs placebo

- PMLiVE

Uniphar announces US expansion and company integration

The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle

- PMLiVE

Turning connection into action: VML Health’s first Patient Advocacy Summit ignites collaboration in Berlin

The summit brought together global leaders to reframe advocacy as the engine of patient-centred change, proving that connected voices can drive collective impact

- PMLiVE

Creativity cages

The surprising way to think out of the box

- PMLiVE

A quest for the crown: ruling digital relevance in the age of LLMs

By Ken Deutsch and Carol Patel

- PMLiVE

The three non-negotiable pillars of Alzheimer’s blood testing

Why sensitivity, access and education will define scalable Alzheimer’s diagnostics

- PMLiVE

Kyowa Kirin and University Hospitals Birmingham announce new survival data in rare disease study

The study demonstrated meaningful survival benefits for patients with cutaneous T cell lymphoma

- PMLiVE

UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome

The study demonstrated a sustained reduction in seizures for patients

- PMLiVE

Navigating the ‘Patient Metro’ – a journey full of insights

The key to unravelling its potential is to focus on the intersections where journeys are made or broken

- PMLiVE

The evolving world of pharma: trends challenges and opportunities

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets are shrinking, targets are climbing, and compliance requirements are getting...

M3 (EU)

- PMLiVE

FDA Fast Track designation given to Enterome’s follicular lymphoma treatment

Follicular lymphoma, a type of non-Hodgkin’s lymphoma, has few initial symptoms

- PMLiVE

Medicus Pharma recruits first patient in cancer patch trial

The first patient has been dosed as part of a phase 2 trial in the UAE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links